Nirmal Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.03 K
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Ebitda -2.84%
- Net Worth -43.11%
- Total Assets -71.17%
About Nirmal Pharmacy
Nirmal Pharmacy Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 June 2018 (Six years and eight months 12 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.03 K , as per Ministry of Corporate Affairs (MCA) records.
Nirmalkumar Choraria, Kushal Choraria, and Vinodkumar Choraria serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85320GJ2018PTC102877
- Company No.
102877
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Nirmal Pharmacy?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmalkumar Choraria  | Director | 16-Jun-2018 | Current |
| Kushal Choraria | Director | 16-Jun-2018 | Current |
| Vinodkumar Choraria | Director | 16-Jun-2018 | Current |
Financial Performance of Nirmal Pharmacy.
Nirmal Pharmacy Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirmal Pharmacy?
In 2020, Nirmal Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nirmal Hospital Private LimitedNirmalkumar Choraria and Vinodkumar Choraria are mutual person
Nirmal Diagnostic Private LimitedNirmalkumar Choraria and Vinodkumar Choraria are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nirmal Pharmacy?
Unlock and access historical data on people associated with Nirmal Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirmal Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirmal Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.